These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 17043250

  • 1. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
    Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS.
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of EphB4 in head and neck squamous cell carcinoma.
    Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS.
    Ear Nose Throat J; 2003 Nov; 82(11):866, 869-70, 887. PubMed ID: 14661437
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M, Tonomoto Y, Hyakudomi R, Hyakudomi M, Hattori S, Ueda S, Kinugasa S, Yoshimura H.
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [Abstract] [Full Text] [Related]

  • 6. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [Abstract] [Full Text] [Related]

  • 7. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [Abstract] [Full Text] [Related]

  • 8. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J.
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM, Fujimoto J, Jahan I, Sato E, Tamaya T.
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, Chintrakarn C, Pochanukul L.
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [Abstract] [Full Text] [Related]

  • 12. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
    Chang HW, Ling GS, Wei WI, Yuen AP.
    Cancer; 2004 Jul 01; 101(1):125-32. PubMed ID: 15221997
    [Abstract] [Full Text] [Related]

  • 13. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
    Tao L, Lefèvre M, Callard P, Périé S, Bernaudin JF, St Guily JL.
    Otolaryngol Head Neck Surg; 2006 Sep 01; 135(3):445-50. PubMed ID: 16949980
    [Abstract] [Full Text] [Related]

  • 14. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
    Erovic BM, Pammer J, Hollemann D, Woegerbauer M, Geleff S, Fischer MB, Burian M, Frommlet F, Neuchrist C.
    Head Neck; 2003 Oct 01; 25(10):848-57. PubMed ID: 12966509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM, Chan AW, Yu KH, King AD, Wong KT, Chen GG, Tsang RK, Chan AB.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3558-65. PubMed ID: 17929099
    [Abstract] [Full Text] [Related]

  • 17. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
    Bhattacharya N, Roy A, Roy B, Roychoudhury S, Panda CK.
    J Oral Pathol Med; 2009 Nov 01; 38(10):759-63. PubMed ID: 19453846
    [Abstract] [Full Text] [Related]

  • 18. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.
    J Pathol; 2008 Mar 01; 214(4):489-97. PubMed ID: 18213732
    [Abstract] [Full Text] [Related]

  • 19. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T.
    Clin Cancer Res; 2005 May 01; 11(9):3257-64. PubMed ID: 15867221
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of micrometastases detection in lymph nodes from head and neck squamous cell carcinoma.
    Xu Y, Lefèvre M, Périé S, Tao L, Callard P, Bernaudin JF, St Guily JL.
    Otolaryngol Head Neck Surg; 2008 Sep 01; 139(3):436-41. PubMed ID: 18722227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.